Apama Medical™ founded in 2009 by serial entrepreneur Amr Salahieh, is an early-stage medical device company focused on the treatment of atrial fibrillation via a unique and proprietary catheter ablation system.   Recognizing the need for a more effective means of treating atrial fibrillation,   Apama Medical™ has developed a unique catheter-based approach designed to increase procedural efficiency and safety, addressing fundamental obstacles to the more widespread adoption of atrial ablation therapy.   Atrial fibrillation (AF) remains the most common clinically significant cardiac arrhythmia affecting an estimated 3.2 million Americans.

< Back to Portfolio